GlassScriptPhysician profile
Lisa Marie Stringfellow
NPI 1285044339
$8,596.06
in general payments reported to CMS, 2019-2025
54 companies · $2,588 in 2025
The $2,588 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $879 · 2022: $1,153 · 2023: $1,931 · 2024: $2,045 · 2025: $2,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,549 · Education: $14.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,549.40 |
| Education | $14.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,399.42 | 2021-2025 | |
| Novo Nordisk INC | $941.53 | 2021-2025 | Wegovy, Ozempic |
| Pfizer INC. | $788.66 | 2021-2025 | |
| Lilly USA, LLC | $575.78 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $464.92 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $425.48 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $327.07 | 2021-2025 | Repatha, Otezla, Repatha |
| Dexcom, INC. | $284.49 | 2021-2025 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $238.59 | 2021-2025 | Injectafer |
| Abbott Laboratories | $211.49 | 2021-2025 | Freestyle Libre 3, Proclaim, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $190.08 | 2021-2025 | Belsomra, Steglatro, Steglujan |
| Harmony Biosciences LLC | $181.40 | 2022-2025 | Wakix |
| Sanofi-Aventis U.S. LLC | $177.21 | 2021-2025 | |
| Exact Sciences Corporation | $149.07 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $147.21 | 2023-2025 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $146.67 | 2022-2025 | Wellbutrin, Aplenzin |
| Gilead Sciences, INC. | $141.26 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $115.70 | 2023-2025 | Rexulti, Abilify Maintena |
| Bayer Healthcare Pharmaceuticals INC. | $111.84 | 2022-2024 | |
| Axsome Therapeutics, INC. | $106.58 | 2025 | Auvelity |
| Corcept Therapeutics | $105.66 | 2025 | Korlym |
| Esperion Therapeutics, INC. | $93.91 | 2025 | Nexletol |
| Amarin Pharma, INC. | $91.45 | 2021-2022 | |
| Inspire Medical Systems, INC. | $87.95 | 2024-2025 | Inspire |
| Sumitomo Pharma America, INC. | $84.79 | 2024-2025 | Gemtesa |
| Alkermes, INC. | $82.72 | 2025 | Vivitrol |
| Phathom Pharmaceuticals, INC. | $65.48 | 2024 | Voquezna |
| Ardelyx, INC. | $62.76 | 2025 | Ibsrela |
| Lundbeck LLC | $57.26 | 2024-2025 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $52.53 | 2021 | |
| Corium, LLC | $51.71 | 2023 | Adlarity |
| Seqirus USA INC | $48.01 | 2021-2024 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.15 | 2024-2025 | Xifaxan |
| Medtronic, INC. | $44.58 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Idorsia Pharmaceuticals US INC | $43.06 | 2023-2024 | Quviviq |
| Sanofi Pasteur INC. | $41.84 | 2021-2025 | |
| Ironshore Pharmaceuticals INC. | $41.10 | 2023 | Jornay Pm |
| Azurity Pharmaceuticals, INC. | $38.51 | 2024-2025 | Edarbyclor, Edarbi |
| Biohaven Pharmaceuticals, INC. | $37.13 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.89 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $27.22 | 2022 | |
| Neuronetics, INC. | $22.74 | 2025 | Neurostar Tms Therapy System |
| Vertos Medical, INC. | $21.67 | 2024 | Mild Device Kit |
| Vbi Vaccine (Delaware) INC. | $20.95 | 2022 | |
| Astellas Pharma US INC | $19.87 | 2025 | Veozah |
| Collegium Pharmaceutical, INC. | $19.08 | 2025 | Jornay Pm |
| Optinose US, INC. | $18.53 | 2021 | |
| Edwards Lifesciences Corporation | $18.51 | 2022 | |
| Almatica Pharma LLC | $17.00 | 2023 | Loreev Xr |
| Janssen Pharmaceuticals, INC | $16.31 | 2021 | |
| Eisai INC. | $15.60 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.59 | 2021 | |
| Kaleo, INC. | $15.52 | 2022 | |
| Medicomp INC | $14.53 | 2025 | Telepatch Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Stringfellow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.